Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010209 |
---|---|
Receipt number | R000011957 |
Scientific Title | Randomized phase ll study of mFOLFOX6 + bevacizumab or mFOLFOX6+cetuximab in liver only metastasis from KRAS wild type colorectal cancer |
Date of disclosure of the study information | 2013/03/13 |
Last modified on | 2021/03/01 09:39:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/03/11 17:15:16 | ||
2 | Update | 2013/03/12 11:08:05 | Date of disclosure of the study information |
|
3 | Update | 2013/04/05 14:41:10 | UMIN ID1 |
|
4 | Update | 2013/05/07 10:04:06 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
5 | Update | 2014/03/12 13:03:30 | TEL Last name of contact person Last name of contact person Division name Division name Address Address TEL |
|
6 | Update | 2014/10/14 11:18:07 | Institutions |
|
7 | Update | 2014/10/14 11:19:23 | Other related information |
|
8 | Update | 2014/10/14 11:32:23 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
9 | Update | 2015/04/21 17:49:51 | Condition Condition Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
10 | Update | 2015/04/21 17:51:04 | Key inclusion criteria Key inclusion criteria Target sample size |
|
11 | Update | 2015/04/21 18:04:06 | Address Address Institutions |
|
12 | Update | 2015/04/21 18:05:57 | Other related information |
|
13 | Update | 2015/10/01 18:45:50 | Institutions |
|
14 | Update | 2016/03/28 11:06:16 | Institutions |
|
15 | Update | 2016/03/28 11:11:17 | Recruitment status |
|
16 | Update | 2017/04/03 14:43:57 | Last follow-up date Date of closure to data entry |
|
17 | Update | 2017/10/31 16:27:44 | Date trial data considered complete |
|
18 | Update | 2019/10/10 10:32:08 | Recruitment status Date of IRB |
|
19 | Update | 2021/02/27 20:41:35 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
20 | Update | 2021/03/01 09:39:30 | Results |